Dr. David Jon Moliterno, MD

Dr. Moliterno practices at University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare.

Dr. Moliterno's NPI, 1144234154, was assigned on July 27, 2006. Dr. Moliterno graduated from Virginia Commonwealth University, School of Medicine in 1987. Dr. Moliterno holds Kentucky license 38678.

Dr. Moliterno's primary practice is University of Kentucky Albert B. Chandler Hospital, at 800 Rose Street, Lexington, KY 40536 in Fayette County. The practice phone is (859) 257-2278.

Dr. Moliterno's primary practice is University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare. Dr. Moliterno is also affiliated with Lake Cumberland Regional Hospital. The medical group on file is University of Kentucky General Pediatrics. Dmand AI also links Dr. Moliterno to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moliterno practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Moliterno's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Moliterno is licensed in Kentucky.

CMS data shows 2,390 Medicare services from Dr. Moliterno across 7 procedure codes in 2024, for 1,728 Medicare patients. Medicare paid $28,054 for them.

CMS counts 1,728 Medicare patients who saw Dr. Moliterno in 2024. The largest group is 65 to 74, with 687 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moliterno's median patient age at 72, with 52% women.

In 2024, Dr. Moliterno wrote 429 Medicare Part D claims for 74 patients. 79% of them were for generic drugs. CMS names the drug for 290 of them, across 16 drugs with 11 or more claims each, at $54,495 in total drug cost. In 2023, CMS named 332 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Moliterno for performance year 2024, reported as part of a group. Dr. Moliterno accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 129 papers to Dr. Moliterno, published from 2010 to 2025. 2018 was the busiest year, with 8. The most frequent topics are Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors and Drug Therapy, Combination. Dr. Moliterno has published most often in Catheter Cardiovasc Interv. Dr. Moliterno's most frequent co-authors are Usman Baber, MD, George D. Dangas, MD and Mitchell W. Krucoff, MD.

CMS Open Payments shows 22 general payments to Dr. Moliterno from 3 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 99% of the total. Janssen Research & Development, LLC paid the most, $115,234.

Dr. Moliterno graduated from Virginia Commonwealth University, School of Medicine in 1987.